This is a microgia news story, published by IMR Press.
For more microgia news, you can click here:
more microgia newsFor more disease research news, you can click here:
more disease research newsFor more news from IMR Press, you can click here:
more news from IMR PressOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like disease research news, you might also like this article about
microglia. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Alzheimer news, dementia news, disease research news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
mitochondrial dysfunctionIMR Press
•80% Informative
Increasing evidence suggests microglia-mediated neuroinflammation plays a key role in both the initiation and progression of AD.
Multiple signaling pathways are implicated in this process and pharmaceutical interventions are potentially involved in AD treatment.
It is proposed that targeting the signaling pathways in microgia with mitochondrial dysfunction could represent a novel direction for AD treatment..
VR Score
88
Informative language
92
Neutral language
85
Article tone
semi-formal
Language
English
Language complexity
89
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links